Placebo de macitentan 10 mg, MACITENTAN
APHP201037
Phase 2 small_molecule active
Quick answer
Placebo de macitentan 10 mg, MACITENTAN for Inoperable Chronic thromboembolic pulmonary hyperTension, Pneumology is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Inoperable Chronic thromboembolic pulmonary hyperTension, Pneumology
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active